Faeth Therapeutics (FTH) Times Interest Earned (2020 - 2026)
Faeth Therapeutics' (FTH) quarterly Times Interest Earned came in at -$14.04 in Q1 2026, up 8.13% YoY from -$12.98 in Q1 2025, and down 464.78% on a QoQ basis from $3.85 in Q4 2025.
Faeth Therapeutics (FTH) Times Interest Earned (2020 - 2026) Analysis & Trends
Faeth Therapeutics (FTH) has 7 years of Times Interest Earned data on file, last reported at -$14.04 in Q1 2026.
- Quarterly Times Interest Earned rose 8.13% year-over-year to -$14.04 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$15.27 (down 28.39% YoY) and the FY2025 annual result came in at -$0.37, up 34.6% from the prior year.
- Times Interest Earned eased to -$14.04 in Q1 2026, from $3.85 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $63.34 in Q4 2022 to a low of -$486.71 in Q4 2024.
- A 5-year average of -$37.2 and a median of -$4.57 in 2023 frame the typical range for Times Interest Earned.
- The widest YoY moves for Times Interest Earned: up 305.91% in 2022, down 15090.36% in 2022.
- Tracing FTH's Times Interest Earned over 5 years: stood at $63.34 in 2022, then plunged by 107.73% to -$4.89 in 2023, then slumped by 9846.92% to -$486.71 in 2024, then surged by 100.79% to $3.85 in 2025, then tumbled by 464.78% to -$14.04 in 2026.
- The last three Times Interest Earned figures came in at -$14.04 (Q1 2026), $3.85 (Q4 2025), and -$2.55 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 1.42 |
| 10 | Faeth Therapeutics | 182.05 Mn | 182.05 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.84 |
| Mar 31, 2026 | -14.04 |
| Dec 31, 2025 | 3.85 |
| Sep 30, 2025 | -2.55 |
| Jun 30, 2025 | -2.24 |
| Mar 31, 2025 | -15.28 |
| Dec 31, 2024 | -486.71 |
| Sep 30, 2024 | -2.12 |
| Jun 30, 2024 | -1.88 |
| Mar 31, 2024 | -18.90 |
| Dec 31, 2023 | -4.89 |
| Sep 30, 2023 | -3.89 |
| Jun 30, 2023 | -4.57 |
| Mar 31, 2023 | -26.85 |
| Dec 31, 2022 | 63.34 |
| Sep 30, 2022 | -2.04 |
| Jun 30, 2022 | -62.28 |
| Mar 31, 2022 | -51.39 |
| Dec 31, 2021 | -30.76 |
| Sep 30, 2021 | -0.70 |